• Press Release

The Mount Sinai Hospital’s Cardiac Catheterization Lab Awarded Highest Safety Rating in New York State

Three cardiologists also receive distinguished “two-star” ratings for percutaneous coronary interventions; 21st straight year of honors

  • New York, NY
  • (May 06, 2019)

The Cardiac Catheterization Laboratory of Mount Sinai Heart at The Mount Sinai Hospital has received the highest "two-star" safety rating from the New York State Department of Health for percutaneous coronary intervention (PCI), overall and in non-emergency cases. This marks the 21st consecutive year that the Mount Sinai Catheterization Laboratory or its physicians have been awarded the prestigious designation for safety rates significantly exceeding the statewide average. Only three hospitals in the state have this ranking for PCI.

Samin Sharma, MD, Director of Clinical and Interventional Cardiology at The Mount Sinai Hospital; Annapoorna Kini, MD, Director of the Cardiac Catheterization Laboratory at The Mount Sinai Hospital; and Pedro Moreno, Professor of Cardiology at the Icahn School of Medicine at Mount Sinai have also received “two-star” safety ratings for PCI.  The new report shows they performed a combined 6,529 cases, and that Mount Sinai has the most interventional cardiologists in the state with “two-star” ratings.

“Patient safety is our top priority at The Mount Sinai Hospital Cath Lab. Our efficiency and safety outcomes are unparalleled, and we are very proud of this achievement which is only possible because of the talented and dedicated interventional cardiology team,” says leading interventional cardiologist Dr. Sharma.

PCI, also known as angioplasty, is a minimally invasive procedure performed inside a catheterization laboratory. It is used to diagnose and treat patients with heart disease or blocked heart arteries. A thin catheter is threaded through the body, typically from an artery in the groin, to a blocked vessel in the heart. A diagnosed blockage can be removed, often with a stent that is inserted to restore blood flow within the vessel. Patients entering a cardiac catheterization laboratory can range from non-emergency cases experiencing early heart disease symptoms up to emergency cases who are suffering a myocardial infarction or heart attack.

The new data released by the Department of Health reports on the outcomes of patients who were discharged from all 61 statewide cardiac catheterization labs from December 1, 2013, to November 30, 2016. The “Percutaneous Coronary Interventions (PCI) in New York State 2014-2016” report tracked PCI data in overall, non-emergency, and emergency cases.

During this three-year period, Mount Sinai's Cardiac Catheterization Laboratory achieved significantly higher safety and survival rates than the statewide average, even while performing the highest number of PCI procedures in New York (10,888). Mount Sinai's risk-adjusted mortality rate, or RAMR, for all cases (0.90 percent) was significantly lower than the statewide average (1.18 percent). Also, the RAMR mortality rate for non-emergency cases (0.58 percent) was significantly lower than the statewide average (.77 percent).

Of the 10 centers with the highest volume in New York State, Mount Sinai was the only one to have an overall RAMR significantly lower than the statewide rate for non-emergency cases.

“Our procedural outcomes data over the last several years support the statement that we have mastered the art of PCI. As a result, many patients who were considered too high-risk to receive care elsewhere are referred here. As we increasingly accept complex cases, our PCI complications continue to decline, which is a testament to the quality work this Cath Lab achieves," says Dr. Kini. 

“I believe the Mount Sinai Cath Lab remains the top center for PCI for a few reasons. Primarily, we have an extremely talented group of interventionalists and supporting staff. Secondly, we strictly abide by protocols and standards of care, while embracing new technologies, techniques and innovations, and lastly, the compassion and genuine concern for our patients’ health is the top priority for this lab,” says Dr. Moreno.

For more information on The Cardiac Catheterization Laboratory of Mount Sinai Heart at The Mount Sinai Hospital visit this link: https://www.mountsinai.org/locations/interventional-cardiology-cath-lab


About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.